Adam Madl
Pain Medicine · Baldwin City, KSNPI 1922413939
Payments from drug & device makers
What this record shows
18 manufacturers reported payments, led by Abbott at 37.3% of the total. Reporting peaked in 2019 at $4,535 and has fallen 65.1% since, to $1,580 in 2025.
Across 229 payments — averaging $47.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Medtronic$2K
- Nalu Medical, Inc.$1K
- Vertos Medical, Inc.$841
- Pacira Pharmaceuticals Incorporated$792
- Vertiflex, Inc.$659
- plus $1K from 12 others
What the payments were for
- Travel & lodging$4,51641%
- Food & beverage$6,41359%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 130 | $4,076 |
| Medtronic(2 entities) | 24 | $1,607 |
| Nalu Medical, Inc. | 22 | $1,500 |
| Vertos Medical, Inc. | 12 | $841 |
| Pacira Pharmaceuticals Incorporated | 6 | $792 |
| Vertiflex, Inc. | 2 | $659 |
| Stryker | 4 | $508 |
| Nevro Corp. | 4 | $249 |
| Saluda Medical Americas, Inc. | 4 | $181 |
| AbbVie(2 entities) | 7 | $131 |
| SPR Therapeutics, Inc | 1 | $81 |
| Collegium Pharmaceutical, Inc. | 5 | $78 |
| MML US, Inc. | 2 | $67 |
| Boston Scientific | 1 | $62 |
| Tersera Therapeutics LLC | 2 | $34 |
| Averitas Pharma Inc. | 1 | $28 |
| Pfizer | 1 | $17 |
| Relievant Medsystems, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,929 in reported general payments places this provider in the 70th percentile of 64 pain medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 175 | $2,064 |
| Tizanidine Hcl | 23 | $270 |
| Methylprednisolone | 12 | $120 |
| Cephalexin | 25 | $95 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Baldwin City
- Usman LatifKansas City$734K
- Dawood SayedKansas City$649K
- Andrea ChadwickKansas City$269K
- Mayank GuptaOverland Park$199K
- Brian GoentzelWichita$99K
- Brian KimOverland Park$61K
- Jeffrey FosterOverland Park$56K
- Smith ManionShawnee Mission$55K
- Ryan ZwickMerriam$32K
- Christopher LamKansas City$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.